FRANKLIN BIO
LIVE

Serial Number

99035155

Owner

Franklin Biolabs, Inc.

Attorney

Victoria D. Summerfield

Filing Date

Feb 10, 2025

Add to watchlist:

No watchlists yet
View on USPTO

FRANKLIN BIO Trademark

Serial Number: 99035155

FRANKLIN BIO is a trademark filed by Franklin Biolabs, Inc. on February 10, 2025. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Franklin Biolabs, Inc. (3 trademarks)

411 Swedeland Road
King of Prussia, PA 19406

Entity Type: 03

Trademark Details

Filing Date

February 10, 2025

Registration Date

Not Registered

Goods & Services

Custom manufacturing services for others in the fields of viral-based and non-viral vectors, pharmaceuticals, biologics, vaccines, biotechnological medical products, and gene and cell therapy preparations

Pharmaceutical research services; Pharmaceutical drug development and discovery services, namely, providing translational research tools and services, namely, providing scientific research in the field of screening, testing, sequencing, and analysis of DNA- and RNA-encoded genetic material for drug candidate development; cell and gene therapy product development services; Analytical services being scientific research services in the field of drug substance and drug product characterization which are for research use and in accordance with Good Manufacturing Practices (GMP); Preclinical services including pharmacology, pharmacokinetics, and toxicology in well established lab animal models; Scientific research and development and Good Laboratory Practices (GLP) services for bioanalytical testing including immunogenicity, biodistribution and shedding to support pre-clinical (animal) and clinical (human) studies; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing for quality control purposes and analytical scientific advisory services in the fields of therapeutic drug evaluation and development, bioanalytical testing, immunogenicity testing, clinical studies, pre-clinical studies pharmacology, pharmacokinetics, and toxicology; Good Manufacturing Practices (GMP) laboratory and stability testing for quality control purposes and analytical scientific advisory services in the fields of therapeutic drug evaluation and development, bioanalytical testing, immunogenicity testing, clinical studies, pre-clinical studies pharmacology, pharmacokinetics, and toxicology; Providing laboratory research services for others in accordance with the Clinical Laboratory Improvement Amendments (CLIA) program to support the development of gene and cell therapy, biologics, vaccines, pharmaceuticals, and related biotechnological products; Research and development relating to production and analysis of viral-based vectors, pharmaceuticals, biologics, vaccines, biotechnological products, and gene and cell therapy preparations for use in medical research for others

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 20, 2025 TROA
ATTORNEY REVIEW COMPLETED
Oct 7, 2025 ATRV
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jul 21, 2025 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 21, 2025 PARI
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 21, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 21, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 21, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 18, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 13, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 10, 2025 MAFR
NEW APPLICATION ENTERED
Feb 10, 2025 NWAP